Valion Bio Inc (VBIO) Ownership
VBIO ownership summary
as of October 18, 2026- Institutions
- 12.4% of shares outstanding
- Insiders
- 0.63% of shares outstanding
- Shares outstanding
- 1.9M
- Float
- 880K shares available to trade
- Short interest
- 9.96% 88K shares short
- Days to cover
- 0.03 short interest up 128.9% vs prior month
- Institutions 12.42%
- Insiders 0.63%
- Other investors 86.95%
VBIO top institutional holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Murchinson Ltd. | 2.77% | 115K | $134,550 | +115,000 (0.0%) | June 30, 2026 |
| 2 | Sanctuary Advisors, LLC | 1.47% | 61K | $71,610 | — | June 30, 2026 |
| 3 | Marex Group Ltd | 1.31% | 54K | $63,516 | −4,976 (−8.4%) | June 30, 2026 |
| 4 | Virtu Financial LLC | 0.94% | 39K | $45,893 | +39,225 (0.0%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 0.47% | 19K | $22,668 | −68,444 (−77.9%) | June 30, 2026 |
| 6 | HRT FINANCIAL LLC | 0.28% | 11K | $13,411 | −30,957 (−73.0%) | June 30, 2026 |
| 7 | UBS Group AG | 0.27% | 11K | $12,980 | +8,728 (+368.9%) | June 30, 2026 |
| 8 | TWO SIGMA SECURITIES, LLC | 0.24% | 10K | $11,890 | +10,162 (0.0%) | June 30, 2026 |
| 9 | Tower Research Capital LLC | 0.05% | 2,095 | $2,451 | +1,511 (+258.7%) | June 30, 2026 |
| 10 | SBI Securities Co Ltd | <0.01% | 16 | $19 | — | June 30, 2026 |
| 11 | TD Waterhouse Canada Inc | <0.01% | 5 | $6 | +5 (0.0%) | June 30, 2026 |
| 12 | Caitong International Asset Management Co., Limited. | 0.00% | 1 | $1 | — | June 30, 2026 |
| 13 | Susquehanna International Group, LLP | 0.00% | — | — | −14,639 (−100.0%) | March 31, 2026 |
| 14 | Citigroup Inc | 0.00% | — | — | −4,998 (−100.0%) | March 31, 2026 |
| 15 | XTX Topco Ltd | 0.00% | — | — | −10,506 (−100.0%) | June 30, 2026 |
| 16 | Bank of America Corp | 0.00% | — | — | −13 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 16, 6 holders added 175K shares and 7 cut 135K.
VBIO top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.01% | 3,152 | $3,688 | +2,396 (+316.9%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VBIO shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VBIO
Institutional investors own 12.4% of Valion Bio's shares and insiders 0.63%. The largest holder is Murchinson Ltd. with 2.77% of the shares (115K), as of June 30, 2026. Among the top 16 institutions, 6 added shares and 7 reduced their stake in the latest filings. Short interest is 9.96% of the float, or 0.03 days of average trading volume. The share count fell 96.9% since 2014.
Related: VBIO key metrics. See the VBIO stock overview for the latest quote and news.
VBIO ownership FAQ
Who owns the most Valion Bio stock?
The largest shareholders of Valion Bio are Murchinson Ltd. (2.77%), Sanctuary Advisors, LLC (1.47%), Marex Group Ltd (1.31%), Virtu Financial LLC (0.94%), Geode Capital Management, LLC (0.47%).
What percentage of Valion Bio is owned by institutions?
Institutions hold 12.4% of Valion Bio's shares outstanding; insiders hold 0.63%.
Which funds own Valion Bio?
The largest fund holders of Valion Bio are Fidelity Extended Market Index (0.01%).
What is Valion Bio's short interest?
88K shares of Valion Bio were sold short, 9.96% of the float; at the average daily volume it would take 0.03 days to cover.
How many shares of Valion Bio are outstanding?
Valion Bio has 1.9M shares outstanding, of which 880K are in the public float.